drugset / Trial / NCT04224116

Tranexamic Acid Contribution in the Prevention of Perioperative Bleeding in Thoracic Surgery

NCT04224116 ↗

Phase 4 Completed 60 enrolled University Tunis El Manar
RandomizedParallel-groupTriple-blindPrevention

Summary

Bleeding after thoracic surgery is a major cause of perioperative hemodynamic instability and transfusion requirement, which can lead to a rise of morbidity, mortality and costs. The objective of this study is to evaluate the efficiency of tranexamic acid (TA) in the prevention of perioperative bleeding in thoracic hemorrhagic surgery.

Timeline

Start
2014-01-01
Primary completion
2019-10-02
Completion
2019-10-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 2 mg/kg —

Indications